BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11360254)

  • 1. Mutant sodium channels, myotonia, and propofol.
    England JD
    Muscle Nerve; 2001 Jun; 24(6):713-5. PubMed ID: 11360254
    [No Abstract]   [Full Text] [Related]  

  • 2. The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels.
    Haeseler G; Störmer M; Mohammadi B; Bufler J; Dengler R; Piepenbrock S; Leuwer M
    Muscle Nerve; 2001 Jun; 24(6):736-43. PubMed ID: 11360256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paramyotonia congenita and skeletal sodium channelopathy.
    Tamaoka A
    Intern Med; 2003 Sep; 42(9):769-70. PubMed ID: 14518660
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium channelopathies of skeletal muscle result from gain or loss of function.
    Jurkat-Rott K; Holzherr B; Fauler M; Lehmann-Horn F
    Pflugers Arch; 2010 Jul; 460(2):239-48. PubMed ID: 20237798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia.
    Webb J; Cannon SC
    Neurology; 2008 Mar; 70(10):755-61. PubMed ID: 17898326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, electrophysiological and genetic features of a large Australian family with paramyotonia congenita.
    Parasivam S; Krupa M; Slee M; Thyagarajan DE
    Med J Aust; 2009 Mar; 190(6):334-6. PubMed ID: 19296818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thr1313Met mutation in skeletal muscle sodium channels in a Japanese family with paramyotonia congenita.
    Kinoshita M; Sasaki R; Nagano T; Matsuda A; Nakamura S; Takahama M; Ohnuki M; Hasegawa H; Mitarai T; Hirose K
    Intern Med; 2003 Sep; 42(9):856-61. PubMed ID: 14518676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.
    Rajakulendran S; Tan SV; Matthews E; Tomlinson SE; Labrum R; Sud R; Kullmann DM; Schorge S; Hanna MG
    Neurology; 2009 Sep; 73(12):993-5. PubMed ID: 19770477
    [No Abstract]   [Full Text] [Related]  

  • 9. Myotonic disorders.
    Mankodi A
    Neurol India; 2008; 56(3):298-304. PubMed ID: 18974556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of propafenone in paramyotonia congenita.
    Alfonsi E; Merlo IM; Tonini M; Ravaglia S; Brugnoni R; Gozzini A; Moglia A
    Neurology; 2007 Mar; 68(13):1080-1. PubMed ID: 17389319
    [No Abstract]   [Full Text] [Related]  

  • 11. Nav 1.4 slow-inactivation: is it a player in the warm-up phenomenon of myotonic disorders?
    Lossin C
    Muscle Nerve; 2013 Apr; 47(4):483-7. PubMed ID: 23381896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Reasoning: A child with muscle stiffness.
    Ebert SE; Cartwright MS
    Neurology; 2020 Sep; 95(11):e1609-e1612. PubMed ID: 32527974
    [No Abstract]   [Full Text] [Related]  

  • 13. Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization.
    Péréon Y; Lande G; Demolombe S; Nguyen The Tich S; Sternberg D; Le Marec H; David A
    Neurology; 2003 Jan; 60(2):340-2. PubMed ID: 12552059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies.
    Park JH; Lee YW; Park SA; Lee TK; Rho HJ; Sung KB
    Neurologist; 2010 May; 16(3):203-5. PubMed ID: 20445432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
    Bouhours M; Sternberg D; Davoine CS; Ferrer X; Willer JC; Fontaine B; Tabti N
    J Physiol; 2004 Feb; 554(Pt 3):635-47. PubMed ID: 14617673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic discharges discriminate chloride from sodium muscle channelopathies.
    Drost G; Stunnenberg BC; Trip J; Borm G; McGill KC; Ginjaar IH; van der Kooi AW; Zwarts MJ; van Engelen BG; Faber CG; Stegeman DF; Lateva Z
    Neuromuscul Disord; 2015 Jan; 25(1):73-80. PubMed ID: 25454733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy in myotonic disorders and in muscle channelopathies.
    Meola G; Sansone V
    Neurol Sci; 2000; 21(5 Suppl):S953-61. PubMed ID: 11382195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mutation of the Na channel in the severe form of potassium-aggravated myotonia.
    Kubota T; Kinoshita M; Sasaki R; Aoike F; Takahashi MP; Sakoda S; Hirose K
    Muscle Nerve; 2009 May; 39(5):666-73. PubMed ID: 19347921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro studies on muscular effects and side effects of anesthesiology relevant pharmacotherapy].
    Haeseler G; Piepenbrock S; Leuwer M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Sep; 35(9):600-1. PubMed ID: 11050970
    [No Abstract]   [Full Text] [Related]  

  • 20. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
    Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
    Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.